Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-24

Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating topical 2PX (strontium chloride hexahydrate) for chronic lower-limb post-amputation stump pain; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2PX (topical strontium chloride hexahydrate) (Strontium chloride hexahydrate)

Snippet

Sponsor: Smerud Medical Research International AS | Conditions: Stump Pain | Phase 2 | Status: UNKNOWN